PRA Health Sciences and Jumo Announce Partnership
June 19 2017 - 10:00AM
As part of its new Center for Pediatric Clinical Development
initiative, PRA Health Sciences is pleased to announce its
partnership with Jumo. Jumo is an award-winning provider of
educational health care information and resources for children,
families, and caregivers.
“We are excited about this partnership,” said Mark Sorrentino,
Vice President, The Center for Pediatric Clinical Development.
“When it comes to pediatric clinical trials, we know that patients
and caregivers are fearful and there is often a lack of
understanding of what to expect. Jumo’s novel materials aid in the
education and engagement of these trials.”
PRA’s new Center for Pediatric Clinical Development which was
announced earlier this year is looking to bring innovation to
pediatric clinical trial design and implementation and to
facilitate patient recruitment.
“We look forward to collaborating with PRA and finding new and
innovative ways to assist young patients and their families and to
help them remain engaged and motivated in clinical trials,” said
Kate Hersov, Founder, Jumo. “Working with investigators and other
health care professionals, we pride ourselves on our ability to
provide age-appropriate materials that help empower patients and
caregivers and deliver positive and successful outcomes and trial
experiences.”
A provider of consulting services as well as experienced
technical and operational services, The Center for Pediatric
Clinical Development team connects PRA’s pediatric expertise across
functional areas into a single global resource to support all
aspects of client needs related to pediatric product
development.
ABOUT PRA HEALTH SCIENCES
PRA (NASDAQ:PRAH) is one of the world’s leading global CROs by
revenue, providing outsourced clinical development services to the
biotechnology and pharmaceutical industries. PRA’s global clinical
development platform includes more than 70 offices across North
America, Europe, Asia, Latin America, South Africa, Australia and
the Middle East and over 13,300 employees worldwide. Since 2000,
PRA has performed approximately 3,500 clinical trials worldwide. In
addition, PRA has participated in the pivotal or supportive trials
that led to U.S. Food and Drug Administration or international
regulatory approval of more than 70 drugs. To learn more about PRA,
please visit www.prahs.com.
ABOUT JUMO
Jumo is a global health care education company with offices in
New York, London, and Sydney. Founded by a doctor who wanted to
alleviate the fear and uncertainty of children that often
accompanies a clinical diagnosis, Jumo creates comic books, videos,
podcasts, and apps that help children and their families better
understand and manage their health and wellness. Our products
provide individuals with the ability to learn in their way, on
their terms, throughout their medical journey. To learn more
about Jumo, please visit www.JumoHealth.com.
MEDIA INQUIRIES: Christine Rogers, Manager - Public Relations, Corporate Communications
EMAIL: rogerschristine@prahs.com PHONE: +1 919.786.8463
INVESTOR INQUIRIES: InvestorRelations@prahs.com
PRA Health Sciences (NASDAQ:PRAH)
Historical Stock Chart
From Aug 2024 to Sep 2024
PRA Health Sciences (NASDAQ:PRAH)
Historical Stock Chart
From Sep 2023 to Sep 2024